Susquehanna International Group’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,789
| Closed | -$27.5K | – | 5491 |
|
|
2023
Q4 | $27.5K | Buy |
+14,789
| New | +$27.5K | ﹤0.01% | 5632 |
|
|
2023
Q3 | – | Sell |
-7,211
| Closed | -$37.5K | – | 5507 |
|
|
2023
Q2 | $37.5K | Sell |
7,211
-1,680
| -19% | -$8.74K | ﹤0.01% | 5265 |
|
|
2023
Q1 | $77.8K | Buy |
8,891
+5,251
| +144% | +$45.9K | ﹤0.01% | 5329 |
|
|
2022
Q4 | $19.4K | Buy |
+3,640
| New | +$19.4K | ﹤0.01% | 5373 |
|
|
2022
Q3 | – | Sell |
-3,964
| Closed | -$133K | – | 6065 |
|
|
2022
Q2 | $133K | Buy |
3,964
+3,239
| +447% | +$109K | ﹤0.01% | 4850 |
|
|
2022
Q1 | $36K | Buy |
725
+237
| +49% | +$11.8K | ﹤0.01% | 5374 |
|
|
2021
Q4 | $33K | Buy |
+488
| New | +$33K | ﹤0.01% | 5554 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5282 |
|
|
2020
Q2 | – | Sell |
-549
| Closed | -$18K | – | 4199 |
|
|
2020
Q1 | $18K | Buy |
+549
| New | +$18K | ﹤0.01% | 4359 |
|